Published on 02/26/2015
Human Genomics across the Lifespan
Cancer
-
Practical Opportunities to Improve Early Detection and Prevention of Colorectal Cancer (CRC) in Members of High-Risk Families.
-
A Modified Lynch Syndrome Screening Algorithm in Colon Cancer: BRAF Immunohistochemistry Is Efficacious and Cost Beneficial.
-
Adjusting the frequency of mammography screening on the basis of genetic risk: Attitudes among women in the UK.
-
End of cancer-genome project prompts rethink.
-
Family History of Prostate Cancer in Men Being Followed by Active Surveillance Does Not Increase Risk of Being Diagnosed With High-grade Disease.
-
Timing of risk reducing mastectomy in breast cancer patients carrying a BRCA1/2 mutation: retrospective data from the Dutch HEBON study.
-
Genomic Classifier Identifies Men With Adverse Pathology After Radical Prostatectomy Who Benefit From Adjuvant Radiation Therapy.
-
Utility of Next Generation Sequencing Technologies for the Efficient Genetic Resolution of Haematological Disorders.
-
Prevalence of BRCA1 and BRCA2 germline mutations in patients with triple-negative breast cancer.
Wong-Brown Michelle W, Meldrum Cliff J, Carpenter Jane E, Clarke Christine L, Narod Steven A, Jakubowska Anna, Rudnicka Helena, Lubinski Jan, Scott Rodney J.Breast Cancer Res. Treat. 2015 Feb 15.
News/ Reviews/Comments
-
Protein clues to sudden cardiac death mysteries,
by Rebecca Burbidge, PHG Foundation, Feb 26 -
Breast cancer gene breakthrough,
Healthcanal, Feb 24 -
Duchenne, Becker muscular dystrophy 'affects 1 in 5,000 boys in the US',
Medical News Today, Feb 16 -
CDC Key Findings: Population-Based Prevalence of Duchenne and Becker Muscular Dystrophies in the United States
-
Personalized medicine: Great, but some really serious issues,
by Arthur L. Caplan, Medscape, Feb 24 [by free subscription only] -
23andMe gets FDA approval for Bloom Syndrome genetic test,
by Katelyn Busse, National Monitor, Feb 23 -
FDA approves 23andMe's DNA test, but not the one it halted earlier,
by Cecile Janssens, Huffington Blog Post, Feb 23 -
FDA clearance of DTC genetic test gets mixed reviews,
Medscape, Feb 20 [by free subscription only] -
US regulators try to tame 'wild west' of DNA testing,
by Erika Check Hayden, Nature News, Feb 20 -
Data sharing: Make outbreak research open access,
Nature News, Feb 25